{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:10:25Z","timestamp":1789564225639,"version":"build-2803163510"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007397","name":"Charles University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007543","name":"Grantov\u00e1 Agentura, Univerzita Karlova","doi-asserted-by":"publisher","award":["94323"],"award-info":[{"award-number":["94323"]}],"id":[{"id":"10.13039\/100007543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["01KT2304B"],"award-info":[{"award-number":["01KT2304B"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["03ZU2111AB"],"award-info":[{"award-number":["03ZU2111AB"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["03ZU1111LB"],"award-info":[{"award-number":["03ZU1111LB"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032119","name":"Fakultn\u00ed nemocnice v Motole","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032119","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002957","name":"Technische Universit\u00e4t Dresden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Forschung, Technologie und Raumfahrt","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.yexmp.2026.105057","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T10:26:30Z","timestamp":1781691990000},"page":"105057","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Tumor\u2013infiltrating CD8+Ki-67+ and CD8+LAG-3+ T cells are associated with improved patient survival in retroperitoneal dedifferentiated liposarcomas and leiomyosarcomas"],"prefix":"10.1016","volume":"147","author":[{"given":"Iva","family":"Benesova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Stammberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Balko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Pablik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrej","family":"Ozaniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luise","family":"Rupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Lischke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Weitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jirina","family":"Bartunkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekka","family":"Wehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana Ozaniak","family":"Strizova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2026.105057_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15061650","article-title":"Role and potential of different T helper cell subsets in adoptive cell therapy","volume":"15","author":"Andreu-Sanz","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.yexmp.2026.105057_bb0010","doi-asserted-by":"crossref","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexmp.2026.105057_bb0015","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2025.2568725","article-title":"Spatial immunoprofiling of retroperitoneal leiomyosarcomas reveals intratumoral heterogeneity in immune cell infiltration, checkpoint molecule expression, and tertiary lymphoid structures","volume":"57","author":"Benesova","year":"2025","journal-title":"Ann. Med."},{"key":"10.1016\/j.yexmp.2026.105057_bb0020","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s13402-021-00601-4","article-title":"Prognostic role of proliferating CD8+ cytotoxic Tcells in human cancers","volume":"44","author":"Blessin","year":"2021","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.yexmp.2026.105057_bb0025","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1389366","article-title":"PD-L1 and PD-1 and characterization of tumor-infiltrating lymphocytes in high grade sarcomas of soft tissue \u2013 prognostic implications and rationale for immunotherapy","volume":"7","author":"Boxberg","year":"2018","journal-title":"OncoImmunology"},{"key":"10.1016\/j.yexmp.2026.105057_bb0030","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1038\/s41379-021-00864-0","article-title":"Spatial immunoprofiling of the intratumoral and peritumoral tissue of renal cell carcinoma patients","volume":"34","author":"Br\u00fcck","year":"2021","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.yexmp.2026.105057_bb0035","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41568-020-0285-7","article-title":"The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy","volume":"20","author":"Bruni","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexmp.2026.105057_bb0040","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jamcollsurg.2009.10.007","article-title":"Interaction of histologic subtype and histologic grade in predicting survival for soft-tissue sarcomas","volume":"210","author":"Canter","year":"2010","journal-title":"J. Am. Coll. Surg."},{"key":"10.1016\/j.yexmp.2026.105057_bb0045","doi-asserted-by":"crossref","first-page":"25158","DOI":"10.1038\/s41598-025-10290-w","article-title":"Multomic analysis reveals the potential of LAG3 as a prognostic and immune biomarker and its validation in osteosarcoma","volume":"15","author":"Cao","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexmp.2026.105057_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13040930","article-title":"CD8+ T cell subsets as biomarkers for predicting checkpoint therapy outcomes in cancer immunotherapy","volume":"13","author":"Casalegno Gardu\u00f1o","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.yexmp.2026.105057_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1150985","article-title":"Immunohistochemical scoring of LAG-3 in conjunction with CD8 in the tumor microenvironment predicts response to immunotherapy in hepatocellular carcinoma","volume":"14","author":"Cheung","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexmp.2026.105057_bb0060","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1200\/JCO.1996.14.3.869","article-title":"Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group","volume":"14","author":"Coindre","year":"1996","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.yexmp.2026.105057_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15072099","article-title":"Targeting the molecular and immunologic features of leiomyosarcoma","volume":"15","author":"Cope","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.yexmp.2026.105057_bb0070","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/CCO.0000000000000851","article-title":"First and further-line multidisciplinary treatment of retroperitoneal sarcomas","volume":"34","author":"D\u2019Ambrosio","year":"2022","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.yexmp.2026.105057_bb0075","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1038\/s41379-019-0312-y","article-title":"Expression of lymphocyte immunoregulatory biomarkers in bone and soft-tissue sarcomas","volume":"32","author":"Dancsok","year":"2019","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.yexmp.2026.105057_bb0080","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1747340","article-title":"Tumor-associated macrophages and macrophage-related immune checkpoint expression in sarcomas","volume":"9","author":"Dancsok","year":"2020","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.yexmp.2026.105057_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15225469","article-title":"Retroperitoneal soft tissue sarcoma: emerging therapeutic strategies","volume":"15","author":"de Bree","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.yexmp.2026.105057_bb0090","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008739","article-title":"TCF1-positive and TCF1-negative TRM CD8 T cell subsets and cDC1s orchestrate melanoma protection and immunotherapy response","volume":"12","author":"De Le\u00f3n-Rodr\u00edguez","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.yexmp.2026.105057_bb0095","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.yexmp.2026.105057_bb0100","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.it.2021.06.003","article-title":"CD4+ T cells that help B cells \u2013 a proposal for uniform nomenclature","volume":"42","author":"Eisenbarth","year":"2021","journal-title":"Trends Immunol."},{"key":"10.1016\/j.yexmp.2026.105057_bb0105","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.ccell.2023.08.001","article-title":"Tumor immunogenicity dictates reliance on TCF1 in CD8+ T cells for response to immunotherapy","volume":"41","author":"Escobar","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.yexmp.2026.105057_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1504220","article-title":"High density of TCF1+ stem-like tumor-infiltrating lymphocytes is associated with favorable disease-specific survival in NSCLC","volume":"15","author":"F\u00f8rde","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexmp.2026.105057_bb0115","first-page":"200","article-title":"Soft-tissue sarcoma in adults: an update on the current state of histiotype-specific management in an era of personalized medicine","volume":"70","author":"Gamboa","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.yexmp.2026.105057_bb0120","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00432-018-2777-3","article-title":"Primary anatomical site, adjuvant therapy, and other prognostic variables for dedifferentiated liposarcoma","volume":"145","author":"Gootee","year":"2018","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.yexmp.2026.105057_bb0125","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41698-021-00236-6","article-title":"FOXP3+ T cells in uterine sarcomas are associated with favorable prognosis, low extracellular matrix expression and reduced YAP activation","volume":"5","author":"Gultekin","year":"2021","journal-title":"Npj Precis. Oncol."},{"key":"10.1016\/j.yexmp.2026.105057_bb0130","doi-asserted-by":"crossref","DOI":"10.1172\/JCI164809","article-title":"Single-cell characterization of anti\u2013LAG-3 and anti\u2013PD-1 combination treatment in patients with melanoma","volume":"133","author":"Huuhtanen","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yexmp.2026.105057_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2013.00495","article-title":"Rapid detection of dendritic cell and monocyte disorders using CD4 as a lineage marker of the human peripheral blood antigen-presenting cell compartment","volume":"4","author":"Jardine","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexmp.2026.105057_bb0140","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001355","article-title":"Analysis of tumor-infiltrating NK and T cells highlights IL-15 stimulation and TIGIT blockade as a combination immunotherapy strategy for soft tissue sarcomas","volume":"8","author":"Judge","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.yexmp.2026.105057_bb0145","author":"Kassambara"},{"key":"10.1016\/j.yexmp.2026.105057_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.103955","article-title":"The biology and treatment of leiomyosarcomas","volume":"184","author":"Kerrison","year":"2023","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.yexmp.2026.105057_bb0155","article-title":"Increased infiltration of M2-macrophages, T-cells and PD-L1 expression in high grade leiomyosarcomas supports immunotherapeutic strategies","volume":"7","author":"Kostine","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.yexmp.2026.105057_bb0160","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41568-022-00466-1","article-title":"Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities","volume":"22","author":"Laumont","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexmp.2026.105057_bb0165","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1158\/1078-0432.CCR-07-1712","article-title":"Prognostic significance of macrophage infiltration in leiomyosarcomas","volume":"14","author":"Lee","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexmp.2026.105057_bb0170","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/modpathol.2016.139","article-title":"Patterns and prognostic relevance of PD-1 and PD-L1 expression in colorectal carcinoma","volume":"29","author":"Lee","year":"2016","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.yexmp.2026.105057_bb0175","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2018.11.043","article-title":"Dysfunctional CD8 T cells form a proliferative, dynamically regulated compartment within human melanoma","volume":"176","author":"Li","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.yexmp.2026.105057_bb0180","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12935-023-03157-5","article-title":"Prognostic significance of lymphocyte-activation gene 3 (LAG3) in patients with solid tumors: a systematic review, meta-analysis and pan-cancer analysis","volume":"23","author":"Li","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.yexmp.2026.105057_bb0185","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s12967-024-05104-y","article-title":"Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review","volume":"22","author":"Li","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.yexmp.2026.105057_bb0190","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1158\/1078-0432.CCR-24-2499","article-title":"Unraveling Relatlimab-specific biology using biomarker analyses in patients with advanced melanoma in RELATIVITY-047","volume":"31","author":"Lipson","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexmp.2026.105057_bb0195","article-title":"Pan-soft tissue sarcoma analysis of the incidence, survival, and metastasis: a population-based study focusing on distant metastasis and lymph node metastasis","volume":"12","author":"Liu","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.yexmp.2026.105057_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellin.2024.100146","article-title":"PD-1-mediated inhibition of T cell activation: mechanisms and strategies for cancer combination immunotherapy","volume":"3","author":"Liu","year":"2024","journal-title":"Cell Insight"},{"key":"10.1016\/j.yexmp.2026.105057_bb0205","doi-asserted-by":"crossref","DOI":"10.1038\/srep15651","article-title":"Secreted factors from colorectal and prostate cancer cells skew the immune response in opposite directions","volume":"5","author":"Lundholm","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexmp.2026.105057_bb0210","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-10-112","article-title":"The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time","volume":"10","author":"Ma","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.yexmp.2026.105057_bb0215","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00795-017-0165-8","article-title":"CD163-positive cancer cells are potentially associated with high malignant potential in clear cell renal cell carcinoma","volume":"51","author":"Ma","year":"2017","journal-title":"Med. Mol. Morphol."},{"key":"10.1016\/j.yexmp.2026.105057_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.csbj.2018.11.004","article-title":"Fates of CD8+ T cells in tumor microenvironment","volume":"17","author":"Maimela","year":"2019","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.yexmp.2026.105057_bb0225","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.yexmp.2026.105057_bb0230","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001014","article-title":"LAG-3: from molecular functions to clinical applications","volume":"8","author":"Maruhashi","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.yexmp.2026.105057_bb0235","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/pin.13144","article-title":"CD163-positive cancer cells are a predictor of a worse clinical course in lung adenocarcinoma","volume":"71","author":"Matsubara","year":"2021","journal-title":"Pathol. Int."},{"key":"10.1016\/j.yexmp.2026.105057_bb0240","doi-asserted-by":"crossref","first-page":"5192","DOI":"10.1158\/1078-0432.CCR-24-1782","article-title":"Predictive and dynamic signature for antiangiogenics in combination with a PD1 inhibitor in soft-tissue sarcoma: correlative studies linked to the IMMUNOSARC trial","volume":"30","author":"Moura","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexmp.2026.105057_bb0245","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1158\/2326-6066.CIR-13-0214","article-title":"IL-10: master switch from tumor-promoting inflammation to antitumor immunity","volume":"2","author":"Oft","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.yexmp.2026.105057_bb0250","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.cell.2017.05.005","article-title":"Interferon-\u03b3 drives Treg fragility to promote anti-tumor immunity","volume":"169","author":"Overacre-Delgoffe","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.yexmp.2026.105057_bb0255","doi-asserted-by":"crossref","first-page":"28810","DOI":"10.1038\/s41598-024-80450-x","article-title":"Prognostic significance of CD8 and TCF1 double positive T cell subset in microsatellite unstable gastric cancer","volume":"14","author":"Park","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexmp.2026.105057_bb0260","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41586-019-1906-8","article-title":"B cells are associated with survival and immunotherapy response in sarcoma","volume":"577","author":"Petitprez","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.yexmp.2026.105057_bb0265","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/s41419-025-08376-4","article-title":"Th17-like cells and immunosuppressive macrophages infiltrate tertiary lymphoid structures with distinct maturation status in soft-tissue sarcoma","volume":"16","author":"Petroni","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.yexmp.2026.105057_bb0270","doi-asserted-by":"crossref","first-page":"331","DOI":"10.20892\/j.issn.2095-3941.2018.0306","article-title":"LAG-3 expression on tumor-infiltrating T cells in soft tissue sarcoma correlates with poor survival","volume":"16","author":"Que","year":"2019","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.yexmp.2026.105057_bb0275","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14194578","article-title":"The immune contexture of liposarcoma and its clinical implications","volume":"14","author":"Resag","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.yexmp.2026.105057_bb0280","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1185197","article-title":"Prognostic impact of the post-treatment T cell composition and spatial organization in soft tissue sarcoma patients treated with neoadjuvant hyperthermic radio(chemo)therapy","volume":"14","author":"Rupp","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexmp.2026.105057_bb0285","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.01040","article-title":"Prognostic value of lymphocyte-activation gene 3 (LAG3) in cancer: a meta-analysis","volume":"9","author":"Saleh","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.yexmp.2026.105057_bb0290","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001053","article-title":"CD163+ cytokine-producing cDC2 stimulate intratumoral type 1 T cell responses in HPV16-induced oropharyngeal cancer","volume":"8","author":"Santegoets","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.yexmp.2026.105057_bb0295","series-title":"Cell Detection with Star-convex Polygons","first-page":"265","author":"Schmidt","year":"2018"},{"key":"10.1016\/j.yexmp.2026.105057_bb0300","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1896658","article-title":"Influence of tumor-infiltrating immune cells on local control rate, distant metastasis, and survival in patients with soft tissue sarcoma","volume":"10","author":"Smolle","year":"2021","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.yexmp.2026.105057_bb0305","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41416-021-01456-0","article-title":"T-regulatory cells predict clinical outcome in soft tissue sarcoma patients: a clinico-pathological study","volume":"125","author":"Smolle","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.yexmp.2026.105057_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107297","article-title":"Fragile Treg cells: traitors in immune homeostasis?","volume":"206","author":"Song","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.yexmp.2026.105057_bb0315","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13045-024-01580-3","article-title":"New strategies in soft tissue sarcoma treatment","volume":"17","author":"Spalato-Ceruso","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.yexmp.2026.105057_bb0320","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1426418","article-title":"Stem-like CD8+ T cells in cancer","volume":"15","author":"Steiner","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexmp.2026.105057_bb0325","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1042\/CS20220531","article-title":"M1\/M2 macrophages and their overlaps \u2013 myth or reality?","volume":"137","author":"Strizova","year":"2023","journal-title":"Clin. Sci."},{"key":"10.1016\/j.yexmp.2026.105057_bb0330","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41417-020-0183-x","article-title":"Revisiting the role of CD4+ T cells in cancer immunotherapy\u2014new insights into old paradigms","volume":"28","author":"Tay","year":"2021","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.yexmp.2026.105057_bb0335","series-title":"Modeling Survival Data: Extending the Cox Model","author":"Therneau","year":"2000"},{"key":"10.1016\/j.yexmp.2026.105057_bb0340","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1001\/jamaoncol.2017.1617","article-title":"Use of PD-1 targeting, macrophage infiltration, and IDO pathway activation in sarcomas","volume":"4","author":"Toulmonde","year":"2018","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.yexmp.2026.105057_bb0345","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00262-019-02322-y","article-title":"An immunosuppressive macrophage profile attenuates the prognostic impact of CD20-positive B cells in human soft tissue sarcoma","volume":"68","author":"Tsagozis","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.yexmp.2026.105057_bb0350","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/s41598-023-28024-1","article-title":"Macrophage numbers in the marginal area of sarcomas predict clinical prognosis","volume":"13","author":"Umakoshi","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexmp.2026.105057_bb0355","doi-asserted-by":"crossref","DOI":"10.1007\/s00262-025-04123-y","article-title":"Divergent therapeutic and prognostic impacts of immunogenic features in undifferentiated pleomorphic sarcoma and myxofibrosarcoma","volume":"74","author":"van Oost","year":"2025","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.yexmp.2026.105057_bb0360","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1531219","article-title":"Prognostic significance of programmed cell death 1 expression on CD8+T cells in various cancers: a systematic review and meta-analysis","volume":"14","author":"Wan","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.yexmp.2026.105057_bb0365","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1158\/1078-0432.CCR-24-3275","article-title":"Prognostic value of CD8+ T cells at the invasive margin is comparable to the immune score in nonmetastatic colorectal Cancer: a prospective multicentric cohort study","volume":"31","author":"Wankhede","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexmp.2026.105057_bb0370","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13071722","article-title":"Treatment strategies for metastatic soft tissue sarcomas","volume":"13","author":"Wiltink","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.yexmp.2026.105057_bb0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-020-01672-3","article-title":"Assessing immune infiltration and the tumor microenvironment for the diagnosis and prognosis of sarcoma","volume":"20","author":"Zhu","year":"2020","journal-title":"Cancer Cell Int."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480026000365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480026000365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:53:14Z","timestamp":1789563194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480026000365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":75,"alternative-id":["S0014480026000365"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2026.105057","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor\u2013infiltrating CD8+Ki-67+ and CD8+LAG-3+ T cells are associated with improved patient survival in retroperitoneal dedifferentiated liposarcomas and leiomyosarcomas","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2026.105057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105057"}}